Supriya Lifescience Receives State Award for Export Leadership

Supriya Lifescience, a global leader in Active Pharmaceutical Ingredients (APIs) with a cGMP-certification has been awarded the Maharashtra State Export Award by the Government of Maharashtra for excellence in export for the FY 2022–23 and 2023–24.

The award ceremony took place on October 13, 2025 at Taj Lands’ End, Mumbai and was awarded to Dr Satish Wagh, Executive Chairman & Whole-Time Director and Dr Saloni Wagh, Managing Director, by Hon’ble Uday Samant, Minister of Industries & Marathi Language and senior officials of the state.

Also Read: Anti-Infectives: How New Research is Shaping Infection Control

This award will further cement Supriya Lifescience’s continual performance excellence in exporting pharmaceutical products and its continuing and key contribution in helping India maintain its position as a trusted global healthcare partner. The range of the company’s presence in over 120 countries spans APIs, Finished Dosage Forms (FDFs) and Contract Development and Manufacturing Organizations (CDMO).

Dr. Satish Wagh expressed gratitude and stated that the honour shows the company’s ongoing commitment to creating and driving global quality standards and being innovative and most importantly delivering affordable healthcare around the globe. Dr. Saloni Wagh added that the prestigious recognition encourages the team to strive for sustainable growth, expand scientific capabilities, and enhance and promote Maharashtra's industrial leadership.

Supriya Lifescience Ltd is a company founded in 1987 and growing its export footprint from its manufacturing facility in Ratnagiri, equipped with state-of-the-art technology and manufacturing practices.  Supriya is certified globally by Health Canada, EUGMP, EDQM, USFDA, NMPA and others.